LigaChem Biosciences Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	98,650	128,912	63,054	117,965	139,940
Short-Term Investments	375,898	365,035	36,871	51,981	40,874
Cash & Short-Term Investments	474,548	493,947	99,925	169,946	180,814
Cash Growth	-3.93%	394.32%	-41.20%	-6.01%	90.81%
Accounts Receivable	11,756	13,717	14,809	12,780	22,457
Other Receivables	14,446	14,713	4,347	6,404	23,827
Receivables	26,203	28,543	19,156	19,184	46,284
Inventory	110.04	212.47	196.83	198.82	270.55
Prepaid Expenses	2,514	1,891	785.42	688.15	1,233
Other Current Assets	18,068	25,668	14,555	1,602	349.11
Total Current Assets	521,442	550,262	134,619	191,619	228,951
Property, Plant & Equipment	27,711	25,313	25,424	26,492	24,432
Long-Term Investments	41,481	46,130	17,340	19,825	22,631
Goodwill	16,081	-	-	-	-
Other Intangible Assets	88,400	8,442	6,901	7,889	8,601
Long-Term Deferred Tax Assets	113.37	338.44	981.16	-	-
Other Long-Term Assets	6,481	107,898	4,143	6,610	8,619
Total Assets	701,815	738,383	189,502	252,530	293,233
Accounts Payable	7,428	7,688	7,095	7,285	6,846
Accrued Expenses	11,251	8,952	11,268	3,764	417.57
Short-Term Debt	-	-	11,847	2,700	-
Current Portion of Long-Term Debt	-	-	-	9,147	2,700
Current Portion of Leases	1,059	480.53	268.56	185.81	158.2
Current Income Taxes Payable	-	46.2	-	-	-
Current Unearned Revenue	-	4.6	5.5	12.48	39.67
Other Current Liabilities	41,354	100,011	6,588	5,508	6,857
Total Current Liabilities	61,092	117,183	37,072	28,603	17,018
Long-Term Debt	-	-	-	-	9,147
Long-Term Leases	1,691	339.34	528.37	216.4	263.35
Long-Term Unearned Revenue	3,666	-	-	-	-
Pension & Post-Retirement Benefits	4,589	4,444	3,365	2,605	3,635
Long-Term Deferred Tax Liabilities	31,078	-	-	1,129	3,928
Other Long-Term Liabilities	58,578	418.28	316.02	378.15	468.07
Total Liabilities	160,695	122,385	41,281	32,932	34,459
Common Stock	18,305	18,305	14,060	12,752	12,117
Additional Paid-In Capital	258,787	571,840	97,523	93,881	349,792
Retained Earnings	211,806	36,331	30,740	105,383	-109,586
Treasury Stock	-13,943	-24,835	-4,879	-	-
Comprehensive Income & Other	32,659	14,357	10,626	6,501	4,945
Total Common Equity	507,614	615,998	148,071	218,516	257,268
Minority Interest	33,506	-	-	-	-
Shareholders' Equity	541,120	615,998	148,221	219,599	258,775
Total Liabilities & Equity	701,815	738,383	189,502	252,530	293,233
Total Debt	2,749	819.87	12,644	12,249	12,269
Net Cash (Debt)	471,798	493,128	87,281	157,697	168,545
Net Cash Growth	-4.32%	464.99%	-44.65%	-6.44%	82.06%
Net Cash Per Share	12968.55	14189.22	3072.85	5628.72	6986.35
Filing Date Shares Outstanding	36.44	36.28	27.98	25.5	24.23
Total Common Shares Outstanding	36.44	36.28	27.98	25.5	24.23
Working Capital	460,350	433,079	97,547	163,016	211,933
Book Value Per Share	13930.30	16978.06	5291.96	8568.24	10615.60
Tangible Book Value	403,133	607,556	141,169	210,627	248,667
Tangible Book Value Per Share	11063.07	16745.38	5045.31	8258.90	10260.69
Land	2,815	2,815	2,815	2,815	2,815
Buildings	16,203	16,188	16,134	16,119	16,104
Machinery	21,423	16,148	13,824	13,135	9,060
Construction In Progress	-	177	-	184.65	174

Source: S&P Global Market Intelligence. Standard template. Financial Sources.